Adjunctive brexpiprazole effective after inadequate antidepressant response

The novel antipsychotic brexpiprazole improved depression symptoms compared with placebo when used as adjunctive therapy for patients who did not respond adequately to a course of antidepressant treatment, according to two studies that examined a total of three different daily doses of brexpiprazole.

Source: The Brown University Psychopharmacology Update - October 20, 2015 Category: Psychiatry Tags: What's New in Research Source Type: research